Search

everythinglearnresearchcommunity

for

Search:↓

Combination therapy with fesoterodine and doxazosin improves bladder function and delays BPH progression.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

Sonirid Duo effectively treats benign prostatic hyperplasia.

The doxazosin plus tamsulosin combination improved symptoms effectively with fewer side effects.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

SHH protein helps nerve regeneration in hypertensive rats.

5-alpha-reductase inhibitors significantly affect the penile tissue of hypertensive rats.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

Dutasteride effectively treats benign prostatic hyperplasia, improving symptoms and quality of life.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

The more lipophilic the progesterone derivative, the better it binds to androgen receptors and has antiandrogenic effects.

Dutasteride more effectively lowers DHT levels in men with enlarged prostates than finasteride.

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

Minoxidil sulfate relaxes muscle by increasing potassium flow, making it a unique muscle relaxer.

New compounds may help treat prostate issues without affecting androgen receptors.

Cyclodextrins improve how steroid drugs work and are used in marketed medications and environmental applications.

Minoxidil helps heart function but doesn't improve exercise ability and may cause complications.

Most patients with hard-to-treat high blood pressure can be managed effectively with various treatments, but no single treatment is perfect.

Minoxidil can cause deadly skin reaction; monitor patients closely.

Minoxidil effectively lowers blood pressure in patients with resistant hypertension.

Dutasteride and finasteride cause kidney damage, with dutasteride being more harmful.

Nitrendipine and nifedipine effectively block muscle contractions, while papaverine relaxes them and minoxidil needs high amounts to work.

Testosterone raises blood pressure and changes kidney protein levels.

Minoxidil boosts plasma renin activity, influenced by control plasma renin activity and changes in sympathetic tone.

People with non-dipper hypertension have higher aldosterone levels, more strain on their heart's venous system, and increased risk of endothelial dysfunction.

Dutasteride may reduce insulin sensitivity and increase body fat.

Myotonic dystrophy should be considered in patients with hair thinning, and genetic counseling is important.

The book is a valuable reference on androgenic disorders for professionals but not suitable for laypeople or medical students.

Finasteride reduces heart enlargement and improves heart function.